ARCP.F Stock Overview
Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ARCpoint Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.075 |
| 52 Week High | CA$0.075 |
| 52 Week Low | CA$0.075 |
| Beta | -1.43 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ARCP.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | n/a | -8.8% | 0.04% |
| 1Y | n/a | -9.2% | 27.3% |
Return vs Industry: Insufficient data to determine how ARCP.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ARCP.F performed against the US Market.
Price Volatility
| ARCP.F volatility | |
|---|---|
| ARCP.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ARCP.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ARCP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | John Constantine | www.arcpointlabs.com |
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. The company operates in two segments, ARCpoint Franchise and AFG Services. It offers clinical healthcare; viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing and screening; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy, respiratory, and blood type testing services, as well as vaccine, vitamin, and supplements injections.
ARCpoint Inc. Fundamentals Summary
| ARCP.F fundamental statistics | |
|---|---|
| Market cap | US$7.04m |
| Earnings (TTM) | -US$534.94k |
| Revenue (TTM) | US$6.31m |
1.1x
P/S Ratio-13.2x
P/E RatioIs ARCP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARCP.F income statement (TTM) | |
|---|---|
| Revenue | US$6.31m |
| Cost of Revenue | US$3.73m |
| Gross Profit | US$2.58m |
| Other Expenses | US$3.11m |
| Earnings | -US$534.94k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0045 |
| Gross Margin | 40.84% |
| Net Profit Margin | -8.48% |
| Debt/Equity Ratio | -121.9% |
How did ARCP.F perform over the long term?
See historical performance and comparison